Electromed (Electromed) EBIT per Share : $0.65 (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Electromed EBIT per Share?

Electromed's EBIT per Share for the three months ended in Mar. 2024 was $0.21. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.65.

During the past 12 months, the average EBIT per Share Growth Rate of Electromed was 88.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -7.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Electromed's EBIT per Share or its related term are showing as below:

ELMD' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -43.1 Med: 3.8 Max: 66
Current: -7.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Electromed was 66.00% per year. The lowest was -43.10% per year. And the median was 3.80% per year.

ELMD's 3-Year EBIT Growth Rate is ranked worse than
65.43% of 726 companies
in the Medical Devices & Instruments industry
Industry Median: 5.75 vs ELMD: -7.40

Electromed's EBIT for the three months ended in Mar. 2024 was $1.84 Mil.

Electromed EBIT per Share Historical Data

The historical data trend for Electromed's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromed EBIT per Share Chart

Electromed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

0.33

0.58

0.35

0.34

0.46

Electromed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.14	0.17	0.02	0.26	0.21

Electromed EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Electromed's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4.008	/	8.701
=	0.46

Electromed's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.841	/	8.893
=	0.21

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.65

Electromed (AMEX:ELMD) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Electromed EBIT per Share Related Terms

Thank you for viewing the detailed overview of Electromed's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromed (Electromed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromed Inc (AMEX:ELMD) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Sixth Avenue NW, New Prague, MN, USA, 56071

Website

https://www.smartvest.com

Electromed Inc is a United States-based company that develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Executives

Andrew Summers	director	601 JEFFERSON STREET, HOUSTON TX 77002
James L. Cunniff	director, officer: CEO and President	500 SIXTH AVE NW, NEW PRAGUE MN 56071
Kathleen Skarvan	officer: Chief Executive Officer	40 WEST HIGHLAND PARK DR NE, HUTCHINSON MN 55350
Bradley M. Nagel	officer: Chief Financial Officer	500 SIXTH AVE NW, NEW PRAGUE MN 56071
Michelle C. Wirtz	officer: Chief Financial Officer	500 SIXTH AVENUE NW,, NEW PRAGUE MN 56071
Christopher G. Holland	officer: Chief Commercial Officer	500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Joseph L. Galatowitsch	director	500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Kathleen A Tune	director	60 SOUTH SIXTH STREET, SUITE 3620, MINNEAPOLIS MN 55402
A Jones Lee	director	54 LOCKE LAKE RD, FRIDLEY MN 55432
Stephen H. Craney	director	25340 SANDPIPER LANE, WINONA MN 55987
Andrea M. Walsh	director	500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
George H. Winn	director	27451 COUNTRY HOLLOWS LANE, NEW PRAGUE MN 56701
Michael Joseph Maccourt	officer: Chief Financial Officer	500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Gregory Fluet	director	14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
John L Erb	director	C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT N., MINNEAPOLIS, MN 55369

Electromed (Electromed) Headlines

From GuruFocus

Electromed Inc (ELMD) Reports 16% Revenue Growth in Q1 FY 2024

By GuruFocus Research • 11-07-2023

Electromed Stock Gives Every Indication Of Being Significantly Overvalued

By GF Value GF Value • 04-06-2021

Electromed Stock Appears To Be Significantly Overvalued

By GF Value GF Value • 06-06-2021

Sidoti Virtual Microcap Investor Conference

By ACCESSWIRE ACCESSWIRE • 11-19-2020